For Immediate Release
Contact: John
M. Martino
Phone Number: (215)895-1186
Date: 3/6/00
University of the
Sciences in Philadelphia Establishes Complementary and Alternative
Medicines Institute
In an effort to
make herbal and other complementary medicines safer and
more effective for Americans, University of the Sciences
in Philadelphia is applying its scientific and clinical
resources to a new venture, the Complementary and Alternative
Medicines Institute.
Funded in part by the Bayer
Corporation, the Institutes research will focus on
analyses of herbs, bioassays, in vitro and in vivo studies,
and clinical evaluations of supplements and other herbal
preparations. Staffed by University of the Sciences in Philadelphia
faculty, the Institute will provide science-based research
expertise in pharmacognosy, clinical pharmacy, pharmaceutical
sciences, physical and analytical chemistry, biological
chemistry, molecular biology and genetics.
"There is a need for solid,
scientific testing, as well as testing of safety and efficacy
of these medications in a clinical setting," explained
Ara Der Marderosian, PhD, scientific director of the Complementary
and Alternative Medicines Institute. Der Marderosian is
a pharmacognosist who is known internationally for his research
on ginseng.
The U.S. lags behind Western
Europe in the standardization of herbal therapies and with
supplement use growing, it is important that manufacturers
and the medical community gain a stronger understanding
of purity and efficacy for many of the herbal preparations.
"Herbal remedies may vary
in safety and efficacy," said Der Marderosian. "A
product might come from a different manufacturer or from
a different batch of herbs. It may have been harvested in
a different season or stored under different conditions.
Because of this lack of standardization, medical practitioners
have been reluctant to prescribe herbal remedies for their
patients "
Today more than 50 percent
of Americans use one or more dietary supplements. However,
consumers are choosing supplements based upon word-of-mouth
recommendations and unsubstantiated claims in the media.
Philip P. Gerbino, president
of University of the Sciences in Philadelphia, explains,
"The establishment of this Institute is a continuation
of our original mission. When we were founded in 1821 as
the Philadelphia College of Pharmacy, a primary goal was
to raise the quality and purity of drugs in the marketplace."
"We think that this will
go a long way to ensure that Americans who chose herbal
preparations will get the safest, most effective medications
available," said Der Marderosian.
University of the Sciences
in Philadelphia is a private, coeducational institution
founded in 1821 as Philadelphia College of Pharmacy, the
first college of pharmacy in North America. USP specializes
in educating students for rewarding health and science careers
through its ten bachelor's, ten master's and four doctoral
degree programs in the health and related sciences.
Bayer Corporations Consumer
Care Division, based in Morristown, NJ, manufactures One-A-Day.
###